GRAIL, Inc. (GRAL) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
13/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinGRAL / S&P 32.10% / 15.20% |
WinGRAL / S&P 23.07% / 15.00% |
LoseGRAL / S&P -20.25% / 50.40% |
| 2026-Q11/3 |
LoseGRAL / S&P -39.62% / -4.33% |
WinGRAL / S&P 19.44% / 11.30% |
LoseGRAL / S&P -82.83% / 27.70% |
| 2025-Q42/3 |
WinGRAL / S&P 44.75% / 2.65% |
WinGRAL / S&P 17.18% / 9.00% |
LoseGRAL / S&P -82.62% / 13.40% |
| 2025-Q32/3 |
WinGRAL / S&P 14.99% / 8.12% |
WinGRAL / S&P 20.53% / 4.61% |
LoseGRAL / S&P -84.33% / 13.45% |
| 2025-Q22/3 |
WinGRAL / S&P 101.33% / 10.94% |
WinGRAL / S&P 22.37% / 4.83% |
LoseGRAL / S&P -86.92% / 10.63% |
| 2025-Q13/3 |
WinGRAL / S&P 43.08% / -4.27% |
WinGRAL / S&P 30.47% / 4.98% |
WinGRAL / S&P 25.01% / 10.57% |
| 2024-Q41/3 |
WinGRAL / S&P 29.72% / 2.41% |
LoseGRAL / S&P GRAL unavailable / 5.25% |
LoseGRAL / S&P GRAL unavailable / 6.15% |
| 2024-Q30/3 |
LoseGRAL / S&P -10.47% / 5.89% |
LoseGRAL / S&P GRAL unavailable / 5.89% |
LoseGRAL / S&P GRAL unavailable / 6.11% |
| 2024-Q20/3 |
LoseGRAL / S&P GRAL unavailable / 4.28% |
LoseGRAL / S&P GRAL unavailable / 5.38% |
LoseGRAL / S&P GRAL unavailable / 5.12% |
| 2024-Q10/3 |
LoseGRAL / S&P GRAL unavailable / 10.56% |
LoseGRAL / S&P GRAL unavailable / 5.71% |
LoseGRAL / S&P GRAL unavailable / 5.59% |
| 2023-Q40/3 |
LoseGRAL / S&P GRAL unavailable / 11.69% |
LoseGRAL / S&P GRAL unavailable / 6.81% |
LoseGRAL / S&P GRAL unavailable / 7.78% |
| 2023-Q30/3 |
LoseGRAL / S&P GRAL unavailable / -3.27% |
LoseGRAL / S&P GRAL unavailable / 7.52% |
LoseGRAL / S&P GRAL unavailable / -5.03% |
| 2023-Q20/3 |
LoseGRAL / S&P GRAL unavailable / 8.74% |
LoseGRAL / S&P GRAL unavailable / 9.50% |
LoseGRAL / S&P GRAL unavailable / -8.57% |
| 2023-Q10/3 |
LoseGRAL / S&P GRAL unavailable / 7.50% |
LoseGRAL / S&P GRAL unavailable / 10.77% |
LoseGRAL / S&P GRAL unavailable / -15.69% |
| 2022-Q40/3 |
LoseGRAL / S&P GRAL unavailable / 7.56% |
LoseGRAL / S&P GRAL unavailable / 11.88% |
LoseGRAL / S&P GRAL unavailable / -17.99% |
| 2022-Q30/3 |
LoseGRAL / S&P GRAL unavailable / -4.88% |
LoseGRAL / S&P GRAL unavailable / 13.47% |
LoseGRAL / S&P GRAL unavailable / -1.41% |
| 2022-Q20/3 |
LoseGRAL / S&P GRAL unavailable / -16.10% |
LoseGRAL / S&P GRAL unavailable / 13.71% |
LoseGRAL / S&P GRAL unavailable / 11.04% |
| 2022-Q10/3 |
LoseGRAL / S&P GRAL unavailable / -4.60% |
LoseGRAL / S&P GRAL unavailable / 15.97% |
LoseGRAL / S&P GRAL unavailable / 42.23% |
| 2021-Q40/3 |
LoseGRAL / S&P GRAL unavailable / 11.03% |
LoseGRAL / S&P GRAL unavailable / 15.00% |
LoseGRAL / S&P GRAL unavailable / 96.40% |
| 2021-Q30/3 |
LoseGRAL / S&P GRAL unavailable / 0.58% |
LoseGRAL / S&P GRAL unavailable / 10.77% |
LoseGRAL / S&P GRAL unavailable / 69.42% |
| 2021-Q20/3 |
LoseGRAL / S&P GRAL unavailable / 8.55% |
LoseGRAL / S&P GRAL unavailable / 6.58% |
LoseGRAL / S&P GRAL unavailable / 51.81% |
| 2021-Q10/3 |
LoseGRAL / S&P GRAL unavailable / 6.17% |
LoseGRAL / S&P GRAL unavailable / -1.06% |
LoseGRAL / S&P GRAL unavailable / 7.39% |
| 2020-Q40/3 |
LoseGRAL / S&P GRAL unavailable / 12.15% |
LoseGRAL / S&P GRAL unavailable / -3.72% |
LoseGRAL / S&P GRAL unavailable / -33.42% |
| 2020-Q30/3 |
LoseGRAL / S&P GRAL unavailable / 8.93% |
LoseGRAL / S&P GRAL unavailable / -2.04% |
LoseGRAL / S&P GRAL unavailable / -27.10% |
| 2020-Q20/3 |
LoseGRAL / S&P GRAL unavailable / 20.54% |
LoseGRAL / S&P GRAL unavailable / -0.46% |
LoseGRAL / S&P GRAL unavailable / -27.11% |
| 2020-Q10/3 |
LoseGRAL / S&P GRAL unavailable / -19.60% |
LoseGRAL / S&P GRAL unavailable / 3.47% |
LoseGRAL / S&P GRAL unavailable / -14.75% |
| 2019-Q40/3 |
LoseGRAL / S&P GRAL unavailable / 9.07% |
LoseGRAL / S&P GRAL unavailable / 5.36% |
LoseGRAL / S&P GRAL unavailable / 2.99% |
| 2019-Q30/3 |
LoseGRAL / S&P GRAL unavailable / 1.70% |
LoseGRAL / S&P GRAL unavailable / 5.02% |
LoseGRAL / S&P GRAL unavailable / 0.21% |
| 2019-Q20/3 |
LoseGRAL / S&P GRAL unavailable / 4.30% |
LoseGRAL / S&P GRAL unavailable / 6.64% |
LoseGRAL / S&P GRAL unavailable / 8.65% |
| 2019-Q10/3 |
LoseGRAL / S&P GRAL unavailable / 13.65% |
LoseGRAL / S&P GRAL unavailable / 8.12% |
LoseGRAL / S&P GRAL unavailable / 14.29% |
| 2018-Q40/3 |
LoseGRAL / S&P GRAL unavailable / -13.52% |
LoseGRAL / S&P GRAL unavailable / 9.05% |
LoseGRAL / S&P GRAL unavailable / 18.23% |
| 2018-Q30/3 |
LoseGRAL / S&P GRAL unavailable / 7.71% |
LoseGRAL / S&P GRAL unavailable / 10.21% |
LoseGRAL / S&P GRAL unavailable / 19.06% |
| 2018-Q20/3 |
LoseGRAL / S&P GRAL unavailable / 3.43% |
LoseGRAL / S&P GRAL unavailable / 9.03% |
LoseGRAL / S&P GRAL unavailable / 14.46% |
| 2018-Q10/3 |
LoseGRAL / S&P GRAL unavailable / -0.76% |
LoseGRAL / S&P GRAL unavailable / 7.68% |
LoseGRAL / S&P GRAL unavailable / 12.46% |
| 2017-Q40/3 |
LoseGRAL / S&P GRAL unavailable / 6.64% |
LoseGRAL / S&P GRAL unavailable / 7.03% |
LoseGRAL / S&P GRAL unavailable / 13.82% |
| 2017-Q30/3 |
LoseGRAL / S&P GRAL unavailable / 4.48% |
LoseGRAL / S&P GRAL unavailable / 5.68% |
LoseGRAL / S&P GRAL unavailable / 17.57% |
| 2017-Q20/3 |
LoseGRAL / S&P GRAL unavailable / 3.09% |
LoseGRAL / S&P GRAL unavailable / 4.83% |
LoseGRAL / S&P GRAL unavailable / 17.74% |
| 2017-Q10/3 |
LoseGRAL / S&P GRAL unavailable / 6.07% |
LoseGRAL / S&P GRAL unavailable / 3.67% |
LoseGRAL / S&P GRAL unavailable / 13.32% |
| 2016-Q40/3 |
LoseGRAL / S&P GRAL unavailable / 3.82% |
LoseGRAL / S&P GRAL unavailable / 2.09% |
LoseGRAL / S&P GRAL unavailable / 7.05% |
| 2016-Q30/3 |
LoseGRAL / S&P GRAL unavailable / 3.85% |
LoseGRAL / S&P GRAL unavailable / 0.20% |
LoseGRAL / S&P GRAL unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | GRAL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 151.60% | 20.78% |
| Annualized return | 151.60% | 20.78% |
5Y · 2024-06-12 to 2026-08-27
| Metric | GRAL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 503.95% | 83.14% |
| Annualized return | 43.28% | 12.86% |
10Y · 2024-06-12 to 2026-08-27
| Metric | GRAL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 503.95% | 319.30% |
| Annualized return | 19.70% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |